Village Malaria Worker Expansion
NCT05045547 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7191
Last updated 2025-03-19
Summary
This project will conduct pragmatic operational research in rural communities served by approximately 12 health centres and 120 village malaria workers in Battambang/Pailin, western Cambodia.
This study is funded by Global Fund/Regional Artemisinin Initiative (RAI3E). The grant reference number is QSE-M-UNOPS-MORU-20864-007-42
Conditions
- Febrile Illness
Sponsors & Collaborators
-
Mahidol Oxford Tropical Medicine Research Unit
collaborator OTHER -
University of Oxford
lead OTHER
Principal Investigators
-
Thomas J Peto, Dr. · Mahidol Oxford Tropical Medicine Research Unit
-
James J Callery, Dr. · Mahidol Oxford Tropical Medicine Research Unit
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-04-17
- Primary Completion
- 2023-06-30
- Completion
- 2023-06-30
Countries
- Cambodia
Study Locations
More Related Trials
-
Rigorous Assessment of P. Vivax Relapses and Primaquine Efficacy for Radical Cure
NCT04706130 ·Status: COMPLETED ·Phase: PHASE4
-
Artemisinin Resistance in Cambodia
NCT00479206 ·Status: COMPLETED ·Phase: NA
-
Targeting High Risk Populations With Enhanced Reactive Case Detection in Southern Lao Peoples Democratic Republic
NCT04416945 ·Status: WITHDRAWN ·Phase: NA
-
Artemisinin-resistant Malaria in Cambodia
NCT01736319 ·Status: COMPLETED
-
Malaria Elimination Pilot Study in Military Forces in Cambodia
NCT02653898 ·Status: UNKNOWN ·Phase: PHASE4
-
Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Myanmar
NCT05025761 ·Status: UNKNOWN ·Phase: NA
-
Artemisone for the Treatment of Uncomplicated Falciparum Malaria in Western Cambodia
NCT00936767 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Study to Compare the Triple ACT AL+AQ With the ACT AL in Cambodia and Vietnam
NCT03355664 ·Status: COMPLETED ·Phase: PHASE3
-
Prevalence Survey of Antimalarial Drug Resistance Markers
NCT03217851 ·Status: COMPLETED
-
Strengthening the Evidence for Policy on the RTS,S/AS01 Malaria Vaccine
NCT05041556 ·Status: RECRUITING
-
Vivax Elimination With Tafenoquine (VET) Study
NCT06575647 ·Status: COMPLETED ·Phase: PHASE4
-
Plasmodium Falciparum Clearance Rates in Response to Artesunate in Eastern Cambodia
NCT01240603 ·Status: COMPLETED
-
Artemisinin Resistance in Cambodia II
NCT00722150 ·Status: COMPLETED ·Phase: NA
-
Reducing the Risk of P. Vivax After Falciparum Infections in Co-endemic Areas
NCT03916003 ·Status: COMPLETED ·Phase: PHASE4
-
Malaria Prevention Cambodia
NCT01624337 ·Status: TERMINATED ·Phase: NA
-
A Controlled Human Vivax Malaria Infection Study Through Inoculation of Infected Erythrocytes
NCT05071079 ·Status: RECRUITING ·Phase: NA
-
Targeted Active Case Detection Among High Risk Populations in Southern Lao Peoples Democratic Republic
NCT03783299 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western Cambodia
NCT00493363 ·Status: COMPLETED ·Phase: NA
-
Mass Screening and Treatment for Reduction of Falciparum Malaria
NCT04093765 ·Status: COMPLETED ·Phase: NA
-
Targeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in Thailand
NCT05052502 ·Status: COMPLETED ·Phase: NA
-
Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso
NCT04695197 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Efficacy of Artesunate-mefloquine and the Relative Roles of Resistance Genetic Markers
NCT02427360 ·Status: COMPLETED
-
Efficacy Study of Amodiaquine-Artesunate and Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria
NCT01567423 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of ASAQ and PD for the Treatment of Uncomplicated Falciparum Malaria in Mainland Tanzania
NCT03431714 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine
NCT04411836 ·Status: COMPLETED ·Phase: PHASE3